158 related articles for article (PubMed ID: 37396165)
1. Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score-matched cohort study.
Du M; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2023; 14():1156620. PubMed ID: 37396165
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
[TBL] [Abstract][Full Text] [Related]
3. Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol.
Li D; Hu Z; Chen Q; Chai W; Cai R; Kuang Y; Lu X
Front Endocrinol (Lausanne); 2022; 13():965863. PubMed ID: 36440198
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
[TBL] [Abstract][Full Text] [Related]
6. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.
Li Z; Jia R; Wang K; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2022; 13():938500. PubMed ID: 35992097
[TBL] [Abstract][Full Text] [Related]
8. Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis.
Duc Thang L; Bao Long H; Thi Thu Trang D; Ngoc Quy P; Thi Mai Phuong G; Thi Hanh B; Trong Thach T; Thi Lien Huong N; Hoang L; Hugues JN
J Formos Med Assoc; 2024 Apr; 123(4):523-529. PubMed ID: 38092654
[TBL] [Abstract][Full Text] [Related]
9. Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis.
Liang Z; Wang Y; Kuang Y
Drug Des Devel Ther; 2020; 14():5459-5467. PubMed ID: 33328724
[TBL] [Abstract][Full Text] [Related]
10. Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study.
Huang J; Xie Q; Lin J; Lu X; Wang N; Gao H; Cai R; Kuang Y
Drug Des Devel Ther; 2019; 13():2553-2563. PubMed ID: 31440037
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response.
Chen ZQ; Ai A; Zhang Y; Li H; Wang JY; Wang L; Ng EHY
Fertil Steril; 2024 Jun; 121(6):937-945. PubMed ID: 38272383
[TBL] [Abstract][Full Text] [Related]
12. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF.
Pai AH; Sung YJ; Li CJ; Lin CY; Chang CL
Reprod Biol Endocrinol; 2023 Aug; 21(1):72. PubMed ID: 37550681
[TBL] [Abstract][Full Text] [Related]
13. Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.
Vaiarelli A; Cimadomo D; Ruffa A; Rania E; Pittana E; Gallo C; Fiorenza A; Alviggi E; Alfano S; Carmelo R; Trabucco E; Alviggi C; Rosaria Campitiello M; Rienzi L; Maria Ubaldi F; Venturella R
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():4-10. PubMed ID: 38171151
[TBL] [Abstract][Full Text] [Related]
14. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
[TBL] [Abstract][Full Text] [Related]
16. Fixed Gonadotropin-Releasing Hormone Antagonist Protocol
Dong M; Sun L; Huang L; Wang F; Zhang X; Liu F
Front Endocrinol (Lausanne); 2021; 12():690575. PubMed ID: 34867773
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study.
Wang N; Lin J; Zhu Q; Fan Y; Wang Y; Fu Y; Kuang Y
Medicine (Baltimore); 2018 Aug; 97(34):e11906. PubMed ID: 30142796
[TBL] [Abstract][Full Text] [Related]
18. Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function.
Xu S; Wang X; Zhang Y; Han Y; Zhang C
Gynecol Endocrinol; 2023 Dec; 39(1):2217263. PubMed ID: 37236243
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.
Shi Z; Zhao W; Wu X; Bi X
Gynecol Endocrinol; 2024 May; 40(1):2352133. PubMed ID: 38749017
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
Zhang S; Yin Y; Li Q; Zhang C
Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]